HSC faculty receives U.S. patent for cancer-fighting therapy

SBS Dr. Porunelloor and Stephen Mathew

When patients are diagnosed with breast or prostate cancer, the treatment course is typically surgery, chemotherapy, hormonal therapy, radiation therapy or a combination of these.

Now, two researchers at the University of North Texas Health Science Center at Fort Worth are working toward a future where patients can be cured in a matter of days with immunotherapy.

Porunelloor Mathew, PhD, Professor, Microbiology, Immunology & Genetics, and Stephen Mathew, PhD, Assistant Professor, Microbiology, Immunology & Genetics, School of Biomedical Sciences, are now one step closer to that goal after recently receiving a U.S. patent for their therapy, “Compositions and methods for activation of NK cells killing of prostate and breast cancer cells.”

The two have been working together on cancer research for the last 20 years, with specific interest in the body’s natural killer, or “NK” cells, and harnessing their potential to cure certain cancers.

“We want to focus now on breast and prostate cancers,” said Dr. Porunelloor Mathew. “They are some of the most common cancers among women and men, respectively, so we have the biggest chance to make a significant impact.”

“In the traditional treatments for these cancers, while most of the cancer cells are killed, there is damage to the healthy cells as well,” he explained. “But when the cancer cells escape from traditional treatments, there is opportunity for the disease to return or metastasize to other parts of the body.”

“The advantage to immunotherapy with NK cells is that they seek out and kill all of the cancer cells, even those that are hidden, so the cancer cannot continue to grow.”

With the patent awarded, the next step for the doctors is to develop this immunotherapy to be compatible for use in humans and take it to clinical trials within the next three to four years.

“If it works, we’ve seen the Food and Drug Administration (FDA) fast-track the approval process,” said Dr. Stephen Mathew. “Our previous discovery has been similarly approved by FDA in the treatment of multiple myeloma, another type of cancer, and the success rates have been significant.”

“There is great potential for harnessing NK cells to cure different cancers. With immunotherapy, we are not using harsh chemicals. We’re making it possible for the body to boost its own immune system,” he added. “Ultimately, nature has its own way of curing — we are just creating a pathway for nature to take its course.”

Recent News

Ashenafi 768x768
  • Our People
|Sep 20, 2023

Dr. Ashenafi Cherkos awarded prestigious AIM-AHEAD Fellowship in Leadership

Dr. Ashenafi Cherkos, assistant professor at The University of North Texas Health Science Center at Fort Worth, has been awarded the prestigious AIM-AHEAD Fellowship in Leadership for the Fall 2023 cohort. Cherkos serves in the School of Public Health’s Department of Population and Community Healt...
  • On Campus
|Sep 20, 2023

Innovate Fort Worth podcast: DJ Perera of New Age Media New Age Learning program

Innovate Fort Worth, the local podcast showcasing local innovation and its dynamic creators, recently featured DJ Perera, a trailblazing artist and educator. Hosted by Cameron Cushman of The University of North Texas Health Science Center at Fort Worth, the podcast episode delves into the intersecti...
Darlene Watkins
  • On Campus
|Sep 20, 2023

HSC student advocates for falls prevention awareness in Tarrant County

Darlene Watkins has dedicated her life to creating healthier and sustainable communities. Her background in interdisciplinary design led her to work with various community organizations from Atlanta to California, but it was her passion for educating aging populations that fueled her desire to wo...
Glenn Forister
  • On Campus
|Sep 19, 2023

HSC’s School of Health Professions to host Health Professions Workforce Symposium

Modern medicine is a team sport, and roughly 60% of that team is composed of practitioners who exist outside of the doctor-nurse paradigm. These vital pillars make up the backbone of the $3 trillion health care sector, and they’re among the fastest-growing professions in the world. From 5 to 8 p....